Jalra 50 mg 28 tablets
Price includes tax
Minimum quantity allowed is .
Maximum quantity allowed is .
The product can be bought in quantity increments of .
Jalra 50 mg 28 tablets:
- Jalra 50 mg 15 Tablets belongs to a class of anti-diabetic medicines called dipeptidyl peptidase 4 (Dpp-4) inhibitors used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet. And exercise alone.
- Jalra 50 mg 15 Tablets can be used alone or in combination with other medicines.
- Type 2 diabetes is a chronic (long-term) condition that affects the way the body processes glucose.
- People with type 2 diabetes either don't produce enough insulin or it can't do its job in the body (insulin resistance).
- Tablet available in the form of
- This hormone is released after a meal to stimulate the secretion of insulin from the pancreas.
- Jalra 50 mg 15 Tablets increases the level of the hormone incretin so that enough insulin can be produced by the pancreas to lower high blood sugar levels.
- Thus, Jalra 50 mg 15 tablets helps in controlling blood sugar levels in type 2 diabetes.
Instructions for use:
- Your doctor will advise you how often to take Jalra 50 mg 15 Tablets based on your medical condition.
- Take Jalra 50 mg 15 tablets as prescribed.
- Take Jalra 50 mg 15 tablets with or without food as directed by your doctor.
- Swallow it whole with a glass of water. Do not crush or break it.
Warnings and precautions:
- You may experience dizziness, nausea, headache, excessive sweating, low blood sugar levels, and tremors in some cases.
- Most of these side effects of Jalra 50 mg Tablet 15's do not require medical attention and resolve gradually over time.
- However, if side effects persist or worsen, please consult your doctor.
- If you are allergic to Jalra 50 mg 15 Tablets or any other medicines, please tell your doctor.
- Jalra 50 mg 15 tablets is not recommended for children under 18 years of age.
- If you are pregnant, breastfeeding or undergoing dialysis, please inform your doctor before taking Jalra 50 mg 15 Tablets.
- Jalra 50 mg 15 tablets is not recommended for patients with diabetic ketoacidosis and type 1 diabetes.
- If you have type 1 diabetes, diabetic ketoacidosis (excessive levels of blood acids called ketones), pancreatic, kidney or liver disease or heart problems, tell your doctor before taking Jalra 50 mg 15 Tablets.
the components:
- Vildagliptin - 50 mg.
